SHELTON CAPITAL MANAGEMENT – CRISPR Therapeutics AG Transaction History
SHELTON CAPITAL MANAGEMENT portfolio value:
$8.61M
portfolio value
SHELTON CAPITAL MANAGEMENT quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -12.10% | -18.15K shares | -500K | $65.35 | 131.85K |
| Q2 2022 | share | 0.00% | 0 shares | -300K | $60.77 | 150K | |
| Q1 2022 | share | 0.00% | 0 shares | -1.95M | $62.77 | 150K | |
| Q4 2021 | share | Increase | +22.95% | 28K shares | -2.28M | $78.85 | 150K |
| Q3 2021 | share | Increase | +38.64% | 34K shares | -591K | $111.93 | 122K |
| Q2 2021 | share | Increase | +10.00% | 8K shares | 4.49M | $161.89 | 88K |
| Q1 2021 | share | Increase | +114.48% | 42.7K shares | 4.03M | $121.85 | 80K |
| Q4 2020 | share | Increase | +16.56% | 5.3K shares | 3.03M | $153.11 | 37.3K |
| Q3 2020 | share | 0.00% | 0 shares | 324K | $83.64 | 32K | |
| Q2 2020 | share | 0.00% | 0 shares | 995K | $73.49 | 32K | |
| Q1 2020 | share | Increase | +39.13% | 9K shares | -44K | $42.41 | 32K |
| Q4 2019 | share | Increase | +4.55% | 1K shares | 499K | $60.91 | 23K |
| Q3 2019 | share | 0.00% | 0 shares | -134K | $40.99 | 22K | |
| Q2 2019 | share | Increase | +3459.87% | 21.38K shares | 1.01M | $47.1 | 22K |
| Q1 2019 | share | Decrease | -95.17% | -12.18K shares | -348.7K | $35.72 | 618 |
| Q4 2018 | share | Increase | +70.67% | 5.3K shares | 33K | $28.57 | 12.8K |
| Q3 2018 | share | 0.00% | 0 shares | -108K | $44.35 | 7.5K | |
| Q2 2018 | share | Increase | 0.00% | 7.5K shares | 441K | $58.76 | 7.5K |